Latest publications for January 2023 from Cochrane Infectious Diseases Group
During January 2023, the CIDG published one new protocol and one new review in Issue 1, 2023 of the Cochrane Database of Systematic Reviews. Further details are below.
Inbaraj LR, Daniel J, Rajendran P, Bhaskar A, Srinivasalu VA, Narayanan MKS, Shewade HD, Kirubakaran R, Scandrett K, Malaisamy M, Takwoingi Y, Padmapriyadarsini C. Truenat MTB assays for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database of Systematic Reviews 2023, Issue 1. Art. No.: CD015543. DOI: 10.1002/14651858.CD015543.
Bauza V, Ye W, Liao J, Majorin F, Clasen T. Interventions to improve sanitation for preventing diarrhoea. Cochrane Database of Systematic Reviews 2023, Issue 1. Art. No.: CD013328. DOI: 10.1002/14651858.CD013328.pub2.
Meet the CIDG team
In this ‘Meet the CIDG staff’ series, we feature Dr Rebecca Kuehn, Clinical Research Associate in Evidence Synthesis.
Cochrane Colloquium 2023
Cochrane UK will be hosting the Cochrane Colloquium at the Queen Elizabeth II (QEII) Centre in London from 4th to 6th September 2023, and Satellite events on 3rd September. This year’s Cochrane Colloquium website has now been launched. The theme is ‘Forward together for trusted evidence’ to explore the challenges for the future around trustworthiness of healthcare data and information whilst also celebrating 30 years of producing trusted evidence.
The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals.